Sneak peek: Zoetis launches Vanguard Recombishield to the market, and other news

Happy Monday, dvm360 readers! We hope that you had a great weekend and are ready to tackle another work week. As we continue to inch closer to the end of the year, we are also getting closer to our final Fetch conference of the year, Fetch Long Beach! Join us and our amazing Fetch faculty for 2 days of learning, networking, and fun! Check out the agenda, events happening at the show, and register here today!

In the meantime, here is what you can find this week on dvm360.com:

• Zoetis recently announced the launch of its Vanguard Recombishield (Bordetella bronchiseptica vaccine), a new injectable vaccine to protect against Bordetella bronchiseptica, which received approval in March 2025.
• Gallant achieved the FDA’s Technical Section Complete for Target Animal Safety, a crucial requirement for the FDA drug approval process, putting them one step closer to becoming the first FDA-approved, ready-to-use stem cell therapy within veterinary medicine.
• Once again this week, we are giving our Vet Blast Podcast episodes this week. To kick off the double feature, Brian Hare, MA, PhD, joins host Adam Christman, DVM, MBA, to talk all about the mindset of puppies. Then, Heidi Lobprise, DVM, DAVDC, will be featured Thursday on the show to talk all about hyaluronic acid in periodontal therapy.
• Our most recent installment of dvm360’s Clinic Center will be available later this week! Check back in on dvm360.com to see all that is happening within the world of veterinary practice openings and expansions across the US.
• In an interview with dvm360, Monica Tarantino, DVM, MBA, explains more about subtle behavior and physical signs that can present in a geriatric canine patient who is suffering from chronic pain.
• And more!